{"nct_id":"NCT04551066","title":"To Evaluate the Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis (LIMBER-313)","status":"TERMINATED","status_verified_date":"2024-12","start_date":"2021-05-27","start_date_type":"ACTUAL","primary_completion_date":"2023-08-03","primary_completion_date_type":"ACTUAL","completion_date":"2024-11-25","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["INCY"]}